Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) is higher in pre-open trading after the company announced they have entered into a major ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE